Smiti Nanda

Smiti Nanda

Auto-generated profile, based on publicly available information

Smiti Nanda

Department of Gynaecology and Obstetrics, Pt. B.D. Sharma University of Health Sciences, Rohtak, India

Research Focus & Metrics

Representative Publications

View All Publications
1 October 2012 in Diabetes Research and Clinical Practice
Verified
Journal Article
Closed access
RRRajesh Rajput
Rajesh Rajput
YYYogesh Yadav
Yogesh Yadav
MRMeena Rajput
Meena Rajput
SNSmiti Nanda
Smiti Nanda

28 February 2020 in Journal of Cancer Education
Verified
Journal Article
Closed access
PDF file
LKLokesh Kadian
Lokesh Kadian
GGGulshan Gulshan
Gulshan Gulshan
SSShivkant Sharma
Shivkant Sharma
IKIndu Kumari
Indu Kumari
CYChetna Yadav
Chetna Yadav
RYRitu Yadav
Ritu Yadav

11 September 2014 in Archives of Gynecology and Obstetrics
Verified
Journal Article
Closed access
PDF file
AMAnkita Mittal
Ankita Mittal
SNSmiti Nanda
Smiti Nanda
JSJyotsna Sen
Jyotsna Sen

2 July 2010 in Archives of Gynecology and Obstetrics
Verified
Journal Article
Closed access
PDF file
KDKrishna Dahiya
Krishna Dahiya
SJShaveta Jain
Shaveta Jain
NDNirmala Duhan
Nirmala Duhan
SNSmiti Nanda
Smiti Nanda
PKParveen Kundu
Parveen Kundu

1 January 2015 in Indian Journal of Endocrinology and Metabolism
Verified
Journal Article
Open access
PDF file
RRRajesh Rajput
Rajesh Rajput
VGVasudha Goel
Vasudha Goel
SNSmiti Nanda
Smiti Nanda
MRMeena Rajput
Meena Rajput
SSShashi Seth
Shashi Seth
Background: Undetected and untreated thyroid disorders are associated with adverse maternal and fetal outcomes. There are limited data on the prevalence of newly diagnosed thyroid disease during pregnancy from India. Therefore, this study was designed to evaluate the prevalence of thyroid dysfunction, especially hypothyroidism during the first trimester of pregnancy. Materials and Methods: The present cross-sectional study was conducted at Department of endocrinology and antenatal clinic in the Obstetrics and Gynecology Pt. B.D. Sharma PGIMS, Rohtak over a period of 1-year. The total sample population comprised of 461 pregnant women with uncomplicated intrauterine singleton pregnancies in the first trimester of gestation without any history of thyroid disease or intake of any thyroid medication. Morning blood samples from the participants were analyzed for thyroid function tests, which included FT3, FT4, thyroid-stimulating hormone (TSH) and anti-thyroid peroxidase antibodies (TPO). Results: A total of 461 women were enrolled for this study. Mean maternal age was 23.79 ± 3.47 years. Median gestational age was 8 weeks 5 days. The median FT3, FT4 and TSH were 3.3 pg/mL, 1.25 ng/dL, and 1.40 mIU/L, respectively. Anti-TPO was elevated in 128 (27.8%) pregnant women. 99 (21.5%) women had sub-clinical hypothyroidism and 39 (39.4%) among them were positive for anti-TPO ( P ≤ 0.001). 2 (0.4%) of women had overt hyperthyroidism, whereas 15 (3.3%) of the women had sub-clinical hyperthyroidism. Conclusion: Considering the immense impact that maternal thyroid dysfunction has on maternal and fetal outcomes, prompt identification of thyroid dysfunction and its timely treatment is essential. Thus, universal screening of pregnant women for thyroid dysfunction should be considered especially in a country like India due to the high prevalence of thyroid dysfunction.

18 January 2023 in Apoptosis
Verified
Journal Article
Closed access
PDF file
CYChetna Yadav
Chetna Yadav
RYRitu Yadav
Ritu Yadav
RCRavindresh Chhabra
Ravindresh Chhabra
SNSmiti Nanda
Smiti Nanda
SRShalu Ranga
Shalu Ranga
PAParul Ahuja
Parul Ahuja